Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors

BMC Cancer

Table 2 Cox multivariate survival analysis for T1 and T2a group

Variables	T1 group (n = 1117)						T2a group (n = 1019)
	5-year OS			5-year DFS			5-year OS			5-year DFS
	HR	95%CI	P	HR	95%CI	P	HR	95%CI	P	HR	95%CI	P
Age(years)	1.008	0.992–1.026	0.327	0.996	0.983–1.010	0.599	1.008	0.993–1.024	0.311	1.005	0.993–1.018	0.398
Histological type			0.061			0.008			< 0.001			0.011
Squamous cell carcinoma	1	-	-	1	-	-	1	-	-	1	-	-
Adenocarcinoma	1.734	1.092–2.753	0.020	1.786	1.241–2.570	0.002	1.613	0.949–2.743	0.078	1.273	0.806–2.008	0.3
Adenosquamous cell carcinoma	1.267	0.559–2.874	0.571	1.041	0.513–2.110	0.912	3.182	1.803–5.617	< 0.001	2.21	1.288–3.792	0.004
initiatreatment modality			0.016			0.001			0.070			0.005
R-CT	1	-	-	1	-	-	1	-	-	1	-	-
ARH	0.637	0.307–1.322	0.226	0.741	0.400–1.375	0.343	0.921	0.572–1.484	0.736	0.932	0.640–1.357	0.714
NACT	1.040	0.481–2.249	0.921	1.227	0.642–2.344	0.535	1.339	0.800–2.243	0.267	1.425	0.950–2.139	0.087

ISSN: 1471-2407